These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 10993024)

  • 1. [Why is it that "only" women with chronic non-valvular atrial fibrillation older than 75 years of age are at higher thromboembolic risk?].
    Lovreglio V
    Ital Heart J Suppl; 2000 Aug; 1(8):1078-9. PubMed ID: 10993024
    [No Abstract]   [Full Text] [Related]  

  • 2. [Prevention of thromboembolism in non-valvular atrial fibrillation].
    Coccheri S; Cosmi B
    Cardiologia; 1999 Dec; 44 Suppl 1(Pt 2):927-9. PubMed ID: 12497850
    [No Abstract]   [Full Text] [Related]  

  • 3. Risk factors, atrial fibrillation and thromboembolic events.
    Novo G; Mansueto P; La Franca ML; Di Leo R; Di Rosa S; Fazio G; Mansueto S; Ferrara F; Novo S
    Int Angiol; 2008 Oct; 27(5):433-8. PubMed ID: 18974708
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Study of combined anticoagulant (fluindione)-aspirin therapy in patients with atrial fibrillation at high risk for thromboembolic complications. A randomized trial (FFAACS)].
    Lechat P; Lardoux H; Mallet A; Sanchez P; Derumeaux G; Lecompte T; Maillard L; Mas JL; Mentré F; Pousset F; Lacomblez L; Pisica G; Solbes-Latourette S; Raynaud P; Chaumet-Riffaud P;
    Therapie; 2000; 55(6):681-9. PubMed ID: 11234463
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Prevention of thromboembolism in non-rheumatic atrial fibrillation: an update].
    Pengo V; De Caterina R
    Ital Heart J Suppl; 2001 Sep; 2(9):972-9. PubMed ID: 11675834
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Anticoagulant treatment of patients with atrial fibrillations: dependent on age and other risk factors for thromboembolism].
    Vink R; van den Brink RB; Levi M
    Ned Tijdschr Geneeskd; 2002 Nov; 146(48):2285-9. PubMed ID: 12497755
    [TBL] [Abstract][Full Text] [Related]  

  • 7. D-dimer level influences thromboembolic events in patients with atrial fibrillation.
    Nozawa T; Inoue H; Hirai T; Iwasa A; Okumura K; Lee JD; Shimizu A; Hayano M; Yano K
    Int J Cardiol; 2006 Apr; 109(1):59-65. PubMed ID: 15992948
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distribution of thromboembolism in valvular versus non-valvular atrial fibrillation.
    Blustin JM; McBane RD; Ketha SS; Wysokinski WE
    Expert Rev Cardiovasc Ther; 2014 Oct; 12(10):1129-32. PubMed ID: 25244622
    [No Abstract]   [Full Text] [Related]  

  • 9. [Thromboembolic risk in atrial fibrillation: new clinical perspectives].
    Villani GQ; Andreoli AM; Villani M; Capucci A
    G Ital Cardiol (Rome); 2008 Oct; 9(10 Suppl 1):22S-26S. PubMed ID: 19195302
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anticoagulant and antiplatelet therapy use in 426 patients with atrial fibrillation undergoing percutaneous coronary intervention and stent implantation implications for bleeding risk and prognosis.
    Ruiz-Nodar JM; Marín F; Hurtado JA; Valencia J; Pinar E; Pineda J; Gimeno JR; Sogorb F; Valdés M; Lip GY
    J Am Coll Cardiol; 2008 Feb; 51(8):818-25. PubMed ID: 18294566
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Thromboembolism in non-rheumatic atrial fibrillation].
    Pengo V
    Haematologica; 2001 Sep; 86(9 Suppl):5-11. PubMed ID: 11759619
    [No Abstract]   [Full Text] [Related]  

  • 12. Warfarin exposure and the risk of thromboembolic and major bleeding events among medicaid patients with atrial fibrillation.
    Boulanger L; Hauch O; Friedman M; Foster T; Dixon D; Wygant G; Menzin J
    Ann Pharmacother; 2006 Jun; 40(6):1024-9. PubMed ID: 16735649
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Paroxysmal atrial fibrillation: why patients experience different symptoms from the same arrhythmia?
    Smeets JL
    Neth J Med; 2005 May; 63(5):154-5. PubMed ID: 15952482
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk of thromboembolism and bleeding after general surgery in patients with atrial fibrillation.
    Vink R; Rienstra M; van Dongen CJ; Levi M; Büller HR; Crijns HJ; van Gelder IC
    Am J Cardiol; 2005 Sep; 96(6):822-4. PubMed ID: 16169369
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thromboembolic prophylaxis in nonrheumatic atrial fibrillation: utilization patterns, efficacy, and complications in a long-term follow-up of community patients.
    Blich M; Gross B
    Int J Cardiol; 2004 Jul; 96(1):89-95. PubMed ID: 15203266
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risks of oral anticoagulant therapy with increasing age.
    Torn M; Bollen WL; van der Meer FJ; van der Wall EE; Rosendaal FR
    Arch Intern Med; 2005 Jul; 165(13):1527-32. PubMed ID: 16009869
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic value of plasma soluble CD40 ligand in patients with chronic non-valvular atrial fibrillation.
    Duygu H; Barisik V; Kurt H; Turk U; Ercan E; Kose S
    Europace; 2008 Feb; 10(2):210-4. PubMed ID: 18184662
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Atrial fibrillation: are there gender differences?
    Michelena HI; Ezekowitz MD
    J Gend Specif Med; 2000; 3(6):44-9. PubMed ID: 11253382
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thromboembolic events occur despite sinus rhythm maintenance in patients treated for atrial fibrillation: The Canadian Trial of Atrial Fibrillation experience.
    Thibault B; Talajic M; Dubuc M; Guerra P; Gagné P; Roy D; Connolly S;
    Can J Cardiol; 2004 Feb; 20(2):195-9. PubMed ID: 15010743
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anticoagulation therapy in patients with chronic atrial fibrillation: a retrospective claims data analysis.
    Harley CR; Riedel AA; Hauch O; Nelson M; Wygant G; Reynolds M
    Curr Med Res Opin; 2005 Feb; 21(2):215-22. PubMed ID: 15801992
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.